ARTemis: Randomized trial with neoadjuvant chemotherapy for patients with early breast cancer

被引：0
|
作者：
Earl, Helena Margaret
Blenkinsop, C.
Grybowicz, L.
Vallier, A-L
Cameron, David A.
Bartlett, John M. S.
Murray, Nicholas
Caldas, Carlos
Thomas, J.
Dunn, Janet A.
Higgins, Helen B.
Hiller, Louise
Hayward, Larry
机构：
[1] Univ Cambridge, Dept Oncol, Cambridge, England
[2] NIHR Cambridge Biomed Res Ctr, Cambridge, England
[3] Univ Warwick, Warwick Clin Trials Unit, Coventry CV4 7AL, W Midlands, England
[4] Cambridge Univ Hosp NHS Fdn Trust, Cambridge Canc Trials Ctr, Cambridge, England
[5] Univ Edinburgh, Edinburgh, Midlothian, Scotland
[6] Univ Edinburgh, Edinburgh Canc Res Ctr, Endocrine Canc Grp, Edinburgh, Midlothian, Scotland
[7] SA Hlth Author, Adelaide, SA, Australia
[8] Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS1144
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Characterization of circulating tumor cells in early breast cancer patients receiving neoadjuvant chemotherapy
    Jakabova, Anna
    Bielcikova, Zuzana
    Pospisilova, Eliska
    Petruzelka, Lubos
    Blasiak, Piotr
    Bobek, Vladimir
    Kolostova, Katarina
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [42] Emergency Department Presentations in Early Breast Cancer Patients Receiving Adjuvant and Neoadjuvant Chemotherapy
    Tang, M.
    Horsley, P.
    Lewis, C.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 74 - 74
  • [43] Neoadjuvant chemotherapy for early breast cancer in young patients: real-world outcomes
    Javed, S. R.
    Mathur, S.
    Desouza, K.
    Konstantis, A.
    Ottaviani, D.
    Raja, F.
    Roylance, R.
    Walsh, T.
    Papadimitraki, E.
    CLINICAL ONCOLOGY, 2025, 38
  • [44] The Impact of Neoadjuvant Chemotherapy on Anxiety in Breast Cancer Patients
    Donovan, C. A.
    Carl, A. M.
    Garreau, J. R.
    Glissmeyer, M.
    Sorenson, L.
    Lewis, J.
    Johnson, N. G.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S73 - S73
  • [45] Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial
    A. Sverrisdottir
    M. Nystedt
    H. Johansson
    T. Fornander
    Breast Cancer Research and Treatment, 2009, 117
  • [46] Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial
    Sverrisdottir, A.
    Nystedt, M.
    Johansson, H.
    Fornander, T.
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 117 (03) : 561 - 567
  • [47] Identification of SNPs associated with response of breast cancer patients to neoadjuvant chemotherapy in the EORTC-10994 randomized phase III trial
    V Le Morvan
    S Litière
    A Laroche-Clary
    S Ait-ouferoukh
    R Bellott
    C Messina
    D Cameron
    H Bonnefoi
    J Robert
    The Pharmacogenomics Journal, 2015, 15 : 63 - 68
  • [48] Time to surgery in early breast cancer treated with neoadjuvant chemotherapy
    Cinausero, M.
    Galli, G.
    Basile, D.
    Gerratana, L.
    Fasola, G.
    De Braud, F.
    Sant, M.
    Paolini, B.
    Di Cosimo, S.
    Puglisi, F.
    ANNALS OF ONCOLOGY, 2017, 28
  • [49] Time to surgery after neoadjuvant chemotherapy for early breast cancer
    Cinausero, M.
    Galli, G.
    Basile, D.
    Gerratana, L.
    Fasola, G.
    De Braud, F.
    Sant, M.
    Paolini, B.
    Puglisi, F.
    Di Cosimo, S.
    ANNALS OF ONCOLOGY, 2017, 28
  • [50] Anemia and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
    Danzinger, Sabine
    Fuegerl, Alexandra
    Pfeifer, Christian
    Bernathova, Maria
    Tendl-Schulz, Kristina
    Seifert, Michael
    CANCER INVESTIGATION, 2021, 39 (6-7) : 457 - 465
12345